EHI
Eagle Health Investments Portfolio holdings
AUM
$405M
This Quarter Return
-9.25%
1 Year Return
+14.19%
3 Year Return
+134.25%
5 Year Return
–
10 Year Return
–
AUM
$429M
AUM Growth
+$429M
(+5.7%)
Cap. Flow
+$65.5M
Cap. Flow
% of AUM
15.26%
Top 10 Holdings %
Top 10 Hldgs %
64.97%
Holding
32
New
4
Increased
12
Reduced
3
Closed
4
Top Buys
| 1 |
Illumina
ILMN
|
$22M |
| 2 |
DexCom
DXCM
|
$14.8M |
| 3 |
Intuitive Surgical
ISRG
|
$13.2M |
| 4 |
10x Genomics
TXG
|
$11.8M |
| 5 |
Outset Medical
OM
|
$10.3M |
Top Sells
| 1 |
Vertex Pharmaceuticals
VRTX
|
$21.4M |
| 2 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$4.28M |
| 3 |
AstraZeneca
AZN
|
$4.14M |
| 4 |
argenx
ARGX
|
$3.64M |
| 5 |
Kymera Therapeutics
KYMR
|
$1.57M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SGEN
1
DELISTED
Seagen Inc. Common Stock
SGEN
| $46.4M | 10.83% | 262,502 +32,000 | +14% | +$5.66M |
|
2
Humana
HUM
$36.5B
| $37.5M | 8.75% | 80,191 +2,300 | +3% | +$1.08M |
|
3
United Therapeutics
UTHR
$13.8B
| $37.5M | 8.75% | 159,238 | – | – |
|
4
IQVIA
IQV
$32.4B
| $27.4M | 6.38% | 126,095 +14,100 | +13% | +$3.06M |
|
|
5
AstraZeneca
AZN
$248B
| $25.3M | 5.9% | 383,065 -62,600 | -14% | -$4.14M |
|
|
6
argenx
ARGX
$43.6B
| $22.8M | 5.33% | 60,300 -9,600 | -14% | -$3.64M |
|
|
7
Illumina
ILMN
$15.8B
| $22M | 5.12% | +119,108 | New | +$22M |
|
8
Alnylam Pharmaceuticals
ALNY
$58.5B
| $21.8M | 5.08% | 149,380 +18,136 | +14% | +$2.65M |
|
9
Natera
NTRA
$23.1B
| $20.2M | 4.72% | 570,994 +123,500 | +28% | +$4.38M |
|
|
10
DexCom
DXCM
$29.5B
| $17.7M | 4.12% | 237,100 +198,200 | +510% | +$14.8M |
|
11
Inspire Medical Systems
INSP
$2.77B
| $17.2M | 4.01% | 94,153 +17,900 | +23% | +$3.27M |
|
|
CANO
12
DELISTED
Cano Health, Inc.
CANO
| $16.7M | 3.9% | 3,816,712 +861,600 | +29% | +$3.77M |
|
13
American Well
AMWL
$111M
| $16.2M | 3.77% | 3,741,413 -69,595 | -2% | -$301K |
|
|
14
Outset Medical
OM
$247M
| $15.1M | 3.53% | 1,018,960 +689,960 | +210% | +$10.3M |
|
|
AXNX
15
DELISTED
Axonics, Inc. Common Stock
AXNX
| $14.5M | 3.39% | 256,465 | – | – |
|
|
16
Intuitive Surgical
ISRG
$170B
| $13.2M | 3.07% | +65,530 | New | +$13.2M |
|
17
Agios Pharmaceuticals
AGIO
$2.19B
| $12.8M | 2.98% | 576,413 +145,000 | +34% | +$3.21M |
|
|
18
10x Genomics
TXG
$1.74B
| $11.8M | 2.76% | +261,200 | New | +$11.8M |
|
19
Adaptive Biotechnologies
ADPT
$2.01B
| $9.83M | 2.29% | 1,214,860 +200,000 | +20% | +$1.62M |
|
|
BPMC
20
DELISTED
Blueprint Medicines
BPMC
| $8.62M | 2.01% | 170,551 | – | – |
|
21
Guardant Health
GH
$8.41B
| $6.13M | 1.43% | 151,960 | – | – |
|
|
CMAX
22
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
| $2.6M | 0.61% | 714,755 | – | – |
|
23
4D Molecular Therapeutics
FDMT
$288M
| $1.83M | 0.43% | 261,423 +129,333 | +98% | +$903K |
|
24
Beam Therapeutics
BEAM
$1.66B
| $1.12M | 0.26% | 28,900 | – | – |
|
25
Arvinas
ARVN
$568M
| $968K | 0.23% | 23,000 | – | – |
|